Semiquantitative RT-PCR method coupled to capillary electrophoresis to study 5α-reductase mRNA isozymes in rat ventral prostate in different androgen status

Molecular and Cellular Biochemistry

Volumn 250, Issue 1-2, 2003, Pages 125-130

  Torres, Jesus M ^a   Gómez Capilla, José A ^a   Ruiz, Estrella ^a   Ortega, Esperanza ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

5 reductase isozymes; Androgens; Capillary electrophoresis; Prostate; Semiquantitative RT PCR

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ISOENZYME; MESSENGER RNA; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; ENZYME ANALYSIS; INTERMETHOD COMPARISON; MALE; NONHUMAN; PROSTATE DISEASE; PROSTATE VENTRAL LOBE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANDROGENS; ANIMALS; CHOLESTENONE 5 ALPHA-REDUCTASE; ELECTROPHORESIS, CAPILLARY; LASERS; MALE; OLIGONUCLEOTIDES; POLYMERASE CHAIN REACTION; PROSTATE; PROTEIN ISOFORMS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTOSTERONE; TRANSCRIPTION, GENETIC;

ANIMALIA; EUKARYOTA;

EID: 0042887053     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024902419502     Document Type: Article

References (27)

1. Steers WD: 5alpha-reductase activity in the prostate. Urology 58: 17-24, 2001
2. Rusell DW, Wilson JD: Steroid 5alpha-reductase: Two genes/two enzymes. Annu Rev Biochem 63: 25-61, 1994
3. Novelli G, Margiotti K, Sangiulo F, Reichardt JK: Pharmacogenetic of human androgens and prostate disease. Pharmacogenomics 2: 65-72, 2001
4. Andersson S, Russel DW: Structural and biochemical properties of cloned expressed human and rat steroid 5α-Reductase. Proc Natl Acad Sci USA 87: 3640-3644, 1990
5. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Rusell DW: Tissue distribution and ontogeny of steroid 5α-Reductase isozyme expression. J Clin Invest 92: 903-910, 1993
6. Jaffe JM, Malkowicz SB, Walker AH, MacBride S, Peschel R, Tomaszewski J, Van Arsdalen K, Wein AJ, Rebbeck TR: Association of SRD5A2 genotype and pathological characterization of prostate tumors. Cancer Res 60: 1626-1630, 2000
7. Latil AG, Azzouri R, Cancel GS, Guillaume EC, Cochan-Priollet B, Berthon PL, Cussenot O: Prostate carcinoma risk and allelic varians of genes involved in androgen biosyntesis and metabolism pathway. Cancer 92: 1130-1137, 2001
8. Shibata A, Stamey TA, McNeal JE, Cheng I, Peehl DM: Genetic polymorphism in the androgen receptor and type II 5alpha-reductase genes in prostate enlargement. J Urol 166: 1560-1564, 2001
9. Kirby RS, Bryan J, Eardly I et al.: Finasteride in the treatment of benign prostatic hyperplasia: A urodynamic evaluation. J Urol 70: 65-72, 1992
10. Kaplan SA: 5α-Reductase inhibitors, what role should they play? Urology 58: 65-70, 2001
11. Brawley OW, Barnes S, Parnes H: The future of prostate cancer prevention. Ann NY Acad Sci 952: 145-152, 2001
12. Iehle C, Radvanyi F, Gil Diez de Medina S, Ouafik LH, Gerard H, Chopin D, Raynaud JP, Martin PM: Differences in steroid 5α-reductase isoenzymes expression between normal and pathological human prostate tissue. J Steroid Biochem Mol Biol 68: 189-195, 1999
13. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
14. Wong H, Anderson WD, Cheng T, Riabowol KT: Monitoring mRNA expression by polymerase chain reaction: The 'primer-dropping' method. Anal Biochem 223: 251-258, 1994
15. Jenkins EP, Andersson S, Imperato-McGinley J, Wilson JD, Russell DW: Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J Clin Invest 89: 293-300, 1992
16. Thigpen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russell DW: Molecular genetics of steroid 5alpha-reductase 2 deficiency. J Clin Invest 90: 799-809, 1992
17. Labrie F, Sugimoto Y, Luu-The V, Simard J, Lachance Y, Bachvarov D, Leblanc G, Durocher F, Paquet N: Structure of human type II 5alpha-reductase gene. Endocrinology 131: 1571-1573, 1992
18. Iehle C, Delos S, Filhol O, Martin PM: Baculovirus-directed expression of human prostatic steroid 5alpha-reductase 1 in an active form. J Steroid Biochem Mol Biol 46: 177-182, 1993
19. Iehle C, Delos S, Guirou O, Tate R, Raynaud JP, Martin PM: Human prostatic steroid 5alpha-reductase isoforms - a comparative study of selective inhibitors. J Steroid Biochem Mol Biol 54: 273-279, 1995
20. Mahendroo MS, Cala KM, Hess DV, Rusell DW: Unexpected virilization in male mice lacking steroid 5α-reductase enzymes. Endocrinology 142: 4652-4662, 2001
21. Smith CM, Ballard SA, Worman N, Buettner R, Masters JRW: 5α-Reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro. J Clin Endocrinol Metab 81: 1361-1366, 1996
22. George FW, Russel DW, Wilson JD: Feed-forward control of prostate growth: Dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5alpha-reductase. Proc Natl Acad Sci USA 88: 8044-8047, 1991
23. Normington K, Russell DW: Tissue distribution and kinetic characteristics of rat steroid 5alpha-reductase isozymes. Evidence for distinct physiological functions. J Biol Chem 267: 19548-19554, 1992
24. Huynh H, Alpert L, Alaoui-Jamali MA, Ng CY, Chan TW: Co administration of finasteride and the pure antioestrogen ICI 182, 780 act synergistically in modulating the IGF system in rat prostate. J Endocrinol 17: 109-118, 2001
25. Boyle P, Robertson C, Lowe F, Roehrborn C: Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 55: 533-539, 2000
26. Poletti A, Negri-Cesi P, Rabuffetti M, Colciago A, Celotti F, Martini L: Transient expression of the 5alpha-reductase type 2 isozyme in the rat brain in late fetal and early postnatal life. Endocrinology 139: 2171-2178, 1998
27. Berman DM, Tian H, Russell DW: Expression and regulation of steroid 5alpha-reductase in the urogenital tract of the fetal rat. Mol Endocrinol 9: 1561-1570, 1995